NCT00493038 - Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis | Biotech Hunter

Enrollment

293

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

SinusitisBacterial Infections

Interventions

DRUG

Moxifloxacin (Avelox, BAY12-8039)

Patients will be administered daily a single moxifloxacin 400 mg tablet for 7 days

DRUG

Amoxicillin/Clavulanate

Patient will be administered daily Amoxicilline/Clavulanate 1000 mg tablets every 8 hours for 10 days

Trial Locations (34)

10126

Torino

10141

Torino

16154

Sestri Ponente

20052

Monza

20122

Milan

20142

Milan

23900

Lecco

24128

Bergamo

25040

Esine

27100

Pavia

28100

Novara

31100

Treviso

33100

Udine

39100

Bolzano

40138

Bologna

47023

Cesena

50126

Florence

53100

Siena

56126

Pisa

63039

San Benedetto del Tronto

70123

Bari

71100

Foggia

73100

Lecce

75100

Matera

81100

Caserta

82100

Benevento

88046

Lamezia Terme

95123

Catania

95126

Catania

97013

Comiso

06122

Perugia

00135

Roma

00151

Roma

00184

Roma